文献速递银屑病与炎症性皮肤病

纳米金颗粒偶联局部甲氨蝶呤可正常化银屑病免疫反应并诱导组织重塑

Nanoparticle-Coupled Topical Methotrexate Can Normalize Immune Responses and Induce Tissue Remodeling in Psoriasis.
PubMed 文献 · J Invest Dermatol · 2019-10-31

该研究在咪喹莫特诱导小鼠模型和AGR129人源异种移植小鼠模型中评估甲氨蝶呤偶联金纳米颗粒(MTX-GNPs)局部治疗银屑病的效果。MTX-GNPs较单用MTX显著减少γδ T细胞、CD4+ T细胞和中性粒细胞,两周局部治疗抑制皮肤增生优于钙泊三醇-倍他米松,并诱导组织重塑和降低白细胞介素-17产生。

要点

  • MTX-GNPs局部治疗在临床前银屑病模型中抗炎效果优于单用MTX。
  • 两周MTX-GNPs局部治疗抑制皮肤增生显著优于钙泊三醇-倍他米松。
  • MTX-GNPs降低移植物中驻留T细胞数量和白细胞介素-17产生。

核心结论

  • MTX-GNPs影响皮肤免疫和基质成分,在临床前银屑病中强效抑制发病机制。
  • MTX-GNPs疗效超过传统MTX和标准治疗,有望成为非甾体局部银屑病治疗选择。

研究设计与样本

  • 研究在咪喹莫特诱导小鼠模型和AGR129人源异种移植小鼠模型中进行。
  • 比较MTX-GNPs与单用MTX、局部钙泊三醇-倍他米松的疗效。

主要发现

  • 在咪喹莫特诱导小鼠模型中,MTX-GNPs较MTX显著减少γδ T细胞、CD4+ T细胞和中性粒细胞。
  • 在AGR129人源异种移植小鼠模型中,两周局部MTX-GNPs治疗抑制皮肤增生显著优于局部钙泊三醇-倍他米松。
  • MTX-GNPs治疗导致深刻组织重塑,包括细胞外基质重组上调及角化和角质化过程下调。
  • MTX-GNPs治疗后移植物中驻留T细胞数量和白细胞介素-17产生大幅下降。
  • MTX和MTX-GNPs均直接阻止T细胞增殖并诱导凋亡,抑制细胞因子产生是GNP和MTX-GNPs的共同机制。

临床怎么用

  • MTX-GNPs局部给药全身和局部耐受性良好,支持其作为非甾体局部银屑病治疗方案的开发。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Methotrexate (MTX) is an antiproliferative drug used for treating inflammatory diseases, including psoriasis. Nevertheless, its use in localized therapy is hindered because of poor transdermal penetration. We show that MTX coupled with gold nanoparticles (GNPs) demonstrates superior antiinflammatory efficacy than MTX alone in an imiquimod-induced mouse model, significantly reducing γδ T cells, CD4+ T cells, and neutrophils. Furthermore, it was well tolerated upon systemic and topical administration. In an AGR129 human xenograft mouse model, two-week topical treatment with MTX-GNPs inhibited skin hyperplasia significantly better than topical calcipotriol-betamethasone and led to profound tissue remodeling, involving the upregulation of extracellular matrix reorganization and the downregulation of cornification and keratinization processes. The number of resident T cells in the grafts, as well as interleukin-17 production, drastically decreased upon MTX-GNP treatment. While both MTX and MTX-GNPs directly prevented the proliferation and induced apoptosis of T cells, the suppression of cytokine production was a shared mechanism of GNP and MTX-GNPs. In conclusion, MTX-GNPs influence immune and stromal components of the skin, leading to the potent inhibition of pathogenesis in preclinical psoriasis. MTX-GNPs surpass the efficacy of conventional MTX and standard of care, emerging as a non-steroidal, topical alternative for psoriasis treatment.

来源:J Invest Dermatol,查看原文。版权归原作者所有。

引用

  1. Özcan A, Sahin D, Impellizzieri D, et al. Nanoparticle-Coupled Topical Methotrexate Can Normalize Immune Responses and Induce Tissue Remodeling in Psoriasis. J Invest Dermatol. 2019. PMID: 31678057. doi:10.1016/j.jid.2019.09.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。